{"id":4650,"date":"2017-05-08T02:18:59","date_gmt":"2017-05-08T06:18:59","guid":{"rendered":"http:\/\/www.mccordweb.com\/weblogs\/?p=4650"},"modified":"2017-05-04T21:00:29","modified_gmt":"2017-05-05T01:00:29","slug":"google-adwords-drug-terms-cause-headaches-medispa-practices","status":"publish","type":"post","link":"https:\/\/www.mccordweb.com\/weblogs\/2017\/05\/08\/google-adwords-drug-terms-cause-headaches-medispa-practices\/","title":{"rendered":"Google AdWords Drug Terms Cause Headaches for MediSpa Practices"},"content":{"rendered":"
\"We<\/a>
We Are a Google Partner Specializing in Search Marketing<\/figcaption><\/figure>\n

AdWords drug terms used on website landing pages are causing AdWords site suspensions for dermatologists and cosmetic surgery practices.<\/p>\n

AdWords has added Botox, Xeomin, Restylane and other commonly used injectables that physicians use for facial rejuvenation on their drug term monitoring list<\/a>. As a result AdWords advertisers are being turned off at the account level and their site is suspended from advertising on AdWords.<\/p>\n

This is a brand new landscape for medical professionals. This past year Google has been very, very picky and seemingly capricious in regards to who they turn off and who they do not when it comes to content and claims. Many medical practices had to clean up their content to promote Coolsculpting with AdWords, but the drug name suspension is a brand new thing, just happening this last week for more than one of our AdWords advertisers.<\/p>\n

Here’s the full list of drugs that Google is now monitoring<\/a> and they do state that they can add to this list at will. Botox, Xeomin,\u00a0 and Restylane appear now on the list.<\/p>\n

It appears that many doctors will now need to register their medical license with Google AdWords in order to show ads or for that matter even show these drug names on their website.<\/p>\n

For savvy solutions for your AdWords program by an experienced Google Partner and Certified AdWords Professional<\/a> make sure to visit my website.<\/p>\n","protected":false},"excerpt":{"rendered":"

AdWords drug terms used on website landing pages are causing AdWords site suspensions for dermatologists and cosmetic surgery practices. AdWords has added Botox, Xeomin, Restylane and other commonly used injectables that physicians use for facial rejuvenation on their drug term monitoring list. As a result AdWords advertisers are being turned off at the account level and their site is suspended from advertising on AdWords. This is a brand new landscape for medical professionals. This past year Google has been very, very picky and seemingly capricious in regards to who they turn off and who they do not when it comes to content and claims. Many medical practices had to clean up their content to promote Coolsculpting with AdWords, but the drug name suspension is a brand new thing, just happening this last week for more than one of our AdWords advertisers. Here’s the full list of drugs that Google is now monitoring and they do state that they can add to this list at will. Botox, Xeomin,\u00a0 and Restylane appear now on the list. It appears that many doctors will now need to register their medical license with Google AdWords in order to show ads or for that matter even show these drug names on their website. For savvy solutions for your AdWords program by an experienced Google Partner and Certified AdWords Professional make sure to visit my website.<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[487,488,492],"tags":[489,493,483],"class_list":["post-4650","post","type-post","status-publish","format-standard","hentry","category-adwords","category-adwords-account-management","category-adwords-services","tag-adwords-account-management","tag-adwords-services","tag-virginia-adwords-services"],"_links":{"self":[{"href":"https:\/\/www.mccordweb.com\/weblogs\/wp-json\/wp\/v2\/posts\/4650","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.mccordweb.com\/weblogs\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.mccordweb.com\/weblogs\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.mccordweb.com\/weblogs\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.mccordweb.com\/weblogs\/wp-json\/wp\/v2\/comments?post=4650"}],"version-history":[{"count":1,"href":"https:\/\/www.mccordweb.com\/weblogs\/wp-json\/wp\/v2\/posts\/4650\/revisions"}],"predecessor-version":[{"id":4651,"href":"https:\/\/www.mccordweb.com\/weblogs\/wp-json\/wp\/v2\/posts\/4650\/revisions\/4651"}],"wp:attachment":[{"href":"https:\/\/www.mccordweb.com\/weblogs\/wp-json\/wp\/v2\/media?parent=4650"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.mccordweb.com\/weblogs\/wp-json\/wp\/v2\/categories?post=4650"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.mccordweb.com\/weblogs\/wp-json\/wp\/v2\/tags?post=4650"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}